Idiopathic pulmonary fibrosis (IPF) occurs when scar tissue builds up in the lungs, causing the walls to stiffen and making ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

A Rochester man celebrated being five years cancer-free Thursday by walking around Mayo Clinic thanking the doctors that saved his life.

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...

Discover NovoCure's Q1 2025 earnings insights, including Optune Lua's NSCLC progress, global market growth, and strong revenue performance.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

Health-care companies ticked up as traders awaited earnings. Shares of Big Pharma company Merck ticked down ahead of its earnings. Summit Therapeutics shares rallied after its lung cancer drug ...

Verastem Oncology said Wednesday that the Food and Drug Administration cleared the company's investigational new drug application for its potential treatment of certain cancers.

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...